DGMed ECT Portal
TR EN

Clearance and Assessment Documents

Device clearances, health technology assessments, trial registration records and manufacturer instructions for use. None of these is a peer-reviewed journal publication: they do not produce evidence but show how evidence is assessed and under what frame a device is on the market.

56documents
4document types
2006–2026document span

Who Cleared What, and When

The 14 FDA 510(k) documents in the archive belong to 6 manufacturers. The 510(k) route shows that a device is substantially equivalent to one already on the market; it does not show that its efficacy was demonstrated.

ManufacturerDocumentsSpan
AngioDynamics52011–2026
Galvanize Therapeutics32022–2026
Oncobionics32006–2008
US Medical Innovations12024–2024
Surgnova Healthcare Technologies12024–2024
Zhejiang Curaway Medical Technology12023–2023

How many assessments each body published

The 25 health technology assessments come from 7 bodies. The existence of a report does not mean a favourable decision: some of the documents here are suspension and consultation decisions.

BodyDocuments
NICE9
G-BA8
AIHTA2
IQWiG2
LBI-HTA2
Heidelberg Üniversite Kliniği1
ACIS_avalia-t1

The records on this page are not included in the portal's publication counts. The oncology corpus and the extended electroporation corpus count electroporation publications only; the documents here are kept in the source archive as context and are reported with their own figures.

The Full Set of Documents

That a device is cleared does not mean its efficacy has been demonstrated; the 510(k) route shows substantial equivalence to a device already on the market. Likewise the existence of an HTA report does not mean a favourable decision: some of the documents here are suspension and consultation decisions.

FDA 510(k) Clearances

Premarket notifications issued by the US Food and Drug Administration for electroporation devices. A clearance is not a publication; it records when, for which manufacturer and under which description a device was cleared.

YearBodyDocumentDocument reference
2026Galvanize TherapeuticsAliya® EX System; Aliya® EX Generator; Aliya® Needle; Aliya®K253826
2026AngioDynamicsNanoKnife Generator (H78720300351US0)K253198
2024US Medical InnovationsCanady Helios Cold Plasma™ XL-1000CP™ Ablation System (XL-10K240297
2024Surgnova Healthcare TechnologiesElectroporation System (N3000)K240376
2024Galvanize TherapeuticsINUMI™ Flex NeedleK233884
2024AngioDynamicsNanoKnife Generator (H78720300301US0); NanoKnife Single ElecK242687
2023Zhejiang Curaway Medical TechnologyIrreversible Electroporation Ablation Generator, IrreversiblK222001
2022Galvanize TherapeuticsAliya(TM) System, Aliya(TM) Generator, Aliya(TM) Needle, AliK212871
2019AngioDynamicsNanoKnife SystemK183385
2015AngioDynamicsNanoKnife SystemK150089
2011AngioDynamicsNANOKNIFE SYSTEMK102329
2008OncobionicsONCOBIONIC SYSTEMK080376
2008OncobionicsONCOBIONIC SYSTEM WITH 6 PROBE OUTPUTK080202
2006OncobionicsONCOBIONIC SYSTEMK060054

Health Technology Assessments

Assessment reports published by bodies such as NICE, G-BA, IQWiG, AIHTA and LBI-HTA. They show how an indication is assessed at country level; they interpret evidence rather than produce it.

YearBodyDocumentDocument reference
2025G-BAKronik bronşitte IRE, askı uzatma taşıyıcı gerekçelerBVh-20-003, TrG
2025G-BAKronik bronşitte IRE, askıya almanın uzatılmasıBVh-20-003
2025G-BAKronik bronşitte IRE, görüş bildirme süreci başlatmaBVh-20-003
2024AIHTALokalize prostat kanserinde SBRT, proton ve IREGuncelleme 2024
2024AIHTAVasküler anomalilerde bleomisin elektroskleroterapi (BEST) sistematik derlemeDSD 137
2023NICEProstat kanserinde IREHealthTech htg688, eski IPG572-IPG768
2021IQWiGKronik bronşitte IRE - H20-03 ek raporu
2021IQWiGKronik bronşitte IRE - SGB V 137h değerlendirmesi
2021G-BAKronik bronşitte IRE, Erprobung süreci başlatma bildirimiBVh-20-003, BAnz
2021G-BAKronik bronşitte IRE, Erprobung yönergesinin askıya alınmasıBVh-20-003
2021G-BAKronik bronşitte IRE, §137h BVh-20-003 kararı
2020G-BAKronik bronşitte IRE, §137h ilk değerlendirme kararıBAh-19-003, BAnz
2020G-BAKronik bronşitte IRE, §137h kararı taşıyıcı gerekçelerBAh-19-003, TrG
2019LBI-HTAKaraciğer ve pankreas kanserinde IRE
2019Heidelberg Üniversite KliniğiKronik bronşitte IRE, G-BA §137h bilgi bildirimi52 s.
2019NICEPrimer karaciğer kanserinde IREHealthTech htg532, eski IPG444-IPG664
2018LBI-HTALokalize prostat kanserinde SBRT, proton ve IRE
2017NICEPankreas kanserinde IREHealthTech htg437, eski IPG579-IPG442
2014ACIS_avalia-tPankreas ve karaciğer kanserinde IRE
2014NICEPrimer bazal ve skuamöz hücreli karsinomda elektrokemoterapiHealthTech htg333, eski IPG478
2014NICEPrimer bazal ve skuamöz hücreli karsinomda elektrokemoterapiIPG478 ilk PDF surumu, 8 s.
2013NICEBöbrek kanserinde IREHealthTech htg303, eski IPG443
2013NICECilt metastazlarında elektrokemoterapiHealthTech htg305, eski IPG446
2013NICEKaraciğer metastazlarında IREHealthTech htg304, eski IPG445
2013NICEPrimer akciğer kanseri ve akciğer metastazlarında IREHealthTech htg302, eski IPG441

Trial Registration Records

Trial registration records taken from the ISRCTN registry. The machine-readable export of the registry is processed separately on the Clinical Trials page; the documents here are the registry's own PDF.

YearBodyDocumentDocument reference
2025ISRCTNCilt kanserinde intratümöral gen elektrotransferi (n=9)ISRCTN15479959
2025ISRCTNIRE klinik çalışma fizibilitesi (n=50)ISRCTN14986389
2023ISRCTNIRE'de BT navigasyonuyla iğne yerleştirme (n=20)ISRCTN55383115
2022ISRCTNBaş-boyun kanserinde ECT etkinliği (n=50)ISRCTN37372189
2022ISRCTNECT'de bleomisin konsantrasyonunun optimizasyonu (n=80)ISRCTN74054653
2022ISRCTNHematolojik malignitelerde WT1 DNA aşısı, IM elektroporasyon (n=184)ISRCTN62678383
2020ISRCTNBazal hücreli karsinomda ECT (n=100)ISRCTN14633165
2020ISRCTNYumuşak doku tümörlerinde perkütan ECT (n=30)ISRCTN11667954
2019ISRCTNMeme kanseri cilt metastazlarında ECT (n=404)ISRCTN56719146
2017ISRCTNHIVIS07 - plazmid DNA-MVA, elektroporasyon (n=48)ISRCTN60284968
2016ISRCTNEURECA - baş-boyun kanserinde ECT Avrupa araştırma projesi (n=120)ISRCTN78463063

Manufacturer Instructions for Use

Instructions for use, technical sheets and brochures published by device manufacturers. These are the manufacturer's own statements, not independent assessments.

YearBodyDocumentDocument reference
2022Galvanize TherapeuticsAliya System 2.5 Kullanım KılavuzuLBL-00054 Rev H
IGEACliniporator EPS02 Kullanım Kılavuzu75 s., ManualsLib
IGEACliniporator EPS02 Teknik SayfaRev 1.1
IGEACliniporator broşürEN
AngioDynamicsNanoKnife Kullanım Kılavuzu96 s., ManualsLib
AngioDynamicsNanoKnife broşürdagitici dokumani